Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma <i>in situ</i> of the bladderMichael S. Cookson, Ronald Tutrone, Samira Q. Harper et al.|Therapeutic Advances in Urology|2014Cited by 50
Single-Particle SERS Enhancement with Optimized Gold-Nanostar MorphologiesThomas Li, Mark H. Griep, Yusong Choi|Unknown|2018Cited by 0